background: Prediction models have been developed in reproductive medicine to help assess the chances of a treatment-(in)dependent pregnancy. Careful evaluation is needed before these models can be implemented in clinical practice.
Introduction
Until recently, the emphasis in reproductive medicine has been on finding causal diagnoses of subfertility followed by treatment of the diagnosed condition. Examples are ovulation induction in women diagnosed with anovulation, tubal surgery in women with bilateral tubal disease and in vitro fertilization (IVF) with assisted fertilization after surgical sperm retrieval in couples with azoospermia. In many couples, such causal factors cannot be found. These couples are classified as having unexplained subfertility, mild male subfertility, cervical factor subfertility, mild endometriosis or one-sided tubal pathology; and assisted reproductive techniques such as intrauterine insemination † Abstract presented at the 24th Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) in Barcelona, Spain (6 -9 July 2008).
(IUI) or IVF are then considered. As these interventions are expensive and not without side effects, they should be offered to a couple only if the expected success rate with treatment substantially exceeds the probability of a spontaneous pregnancy (Wasson et al., 1985; te Velde and Cohlen, 1999) .
It is a clinical challenge for gynaecologists to make such a comparison. Gynaecologists are known to differ widely in their estimations of the probability of achieving a pregnancy for subfertile couples . To help gynaecologists in assessing the chances of pregnancy, prediction models have been developed. With these models, one can calculate the probability of a treatment-independent pregnancy as well as the probability of success with IUI and IVF.
Careful evaluation is needed before these models can be implemented in clinical practice. The use of poor-quality prediction models could have a negative effect on decision making, by introducing the illusion of objective improvement over clinical judgment. We systematically reviewed the literature on the available prediction models in reproductive medicine. We appraised the prediction models according to a published evaluation scheme, distinguishing between model derivation, model validation and impact analysis (McGinn et al., 2000; Reilly and Evans 2006; Steyerberg, 2008) . We also summarized their performance.
Methods

Search strategy and study selection
We performed a structured predefined literature search using MEDLINE, EMBASE and the Cochrane Library from inception to October 2008. An information specialist performed the electronic search using the following terms: pregnancy, live birth, conception, infertility/subfertility/fertility, intrauterine insemination, in vitro fertilization, prediction models and validation. We checked cross-references of eligible papers to identify other papers not captured by electronic searches. No restrictions were held concerning publication year or language. A Reference Manager 11.0 database was established to incorporate results of all citations.
Two reviewers (J.W.S. and E.L.) evaluated potentially eligible papers in a two-stage process. First, papers identified in the search were independently screened for eligibility by reading the title and abstract. If there were any doubts about eligibility after reading the title, we screened the abstract and the full text to make sure no papers were missed. We then obtained full-text versions of all papers selected by at least one of the reviewers in the first stage. Papers were included if they reported on a prediction model for treatment-independent pregnancy, pregnancy after IUI or IVF. If the paper reported on a model for embryo transfer only, it was excluded.
In this review, a prediction model was defined as a model that expressed pregnancy as a function of one or more predictor variables. Such a model can be based on a multivariable regression model, such as a linear, logistic or Cox proportional hazards regressions model. To be eligible, the reported prediction model had to be presented as a score chart, a prediction rule or as a set of regression coefficients with baseline intercept, sufficient to make predictions for individual cases.
Assessment of study quality
For each included paper, we identified the study characteristics and assessed the study quality on the basis of the following items for all models: whether the patient selection was consecutive, whether the data had been collected prospectively, whether the variables and pregnancy (or live birth) were described in sufficient detail and whether missing data were reported and/or imputed ('filled in'). For papers that reported on treatment-independent pregnancy, the basic fertility work-up had to be clearly described, no treatment between basic fertility work-up and time to pregnancy should have been applied and the follow-up duration had to be at least 1 year. We also verified whether papers that reported on treatment-independent models had been derived from Cox proportional hazards analysis with or without right-hand Figure 3 Process from initial search to final inclusion for papers on prediction models in reproductive medicine. 
Patients from Snick et al. (1997) , Collins et al. (1995) and Eimers et al. 1994 a External validation of Snick et al. (1997) , Collins et al. (1995) a For details, see Snick et al. (1997) , Collins et al. (1995) and Eimers et al. (1994 censoring. We added two items for papers that reported on the prediction of treatment-dependent pregnancy (IUI or IVF): whether the diagnosis before treatment was described in sufficient detail and whether the protocol of treatment was described in sufficient detail. We report study quality separately for treatment-independent and treatment-dependent models, i.e. IUI and IVF.
Assessment of model development
We assessed the development of the prediction models with a published evaluation scheme, which distinguishes three phases: model derivation, model validation and impact analysis ( Fig. 1 ) (McGinn et al., 2000; Reilly and Evans 2006; Steyerberg, 2008 ). In the model derivation phase, predictors are identified, based on prior knowledge, and the weight of each predictor (regression coefficient) is calculated. In the second phase, one can distinguish between the internal validation (phase 2a) and the external validation (phase 2b). With internal validation of a prediction model, the model's ability to predict outcome in the group of patients in which it was developed is evaluated, sometimes with data collected in a separate group of patients evaluated in the same setting (Altman and Royston, 2000) . As internal validation systematically gives a too optimistic impression about the quality of the predictions, external validation is a vital next step in assessing the performance of the model (Harrell et al., 1996) . With external validition of a prediction model, the model's ability to predict outcome in populations other than the population in which the model was developed, also called 'generalizability' or 'transportability', is evaluated. The third and final phase consists of impact analysis, which is the evaluation of the implementation of prediction models with documented validity. Impact analysis establishes whether the prediction model improves doctors' decisions by evaluating the effect on patient outcome (Reilly and Evans 2006; Steyerberg, 2008) . This can be evaluated in one (phase 3a) or in varied settings (phase 3b), preferably in a randomized controlled trial.
Assessment of model performance
For the models that were evaluated in an external validation, we quantified the performance of the prediction models by assessing discrimination and calibration. Discrimination refers to the ability to distinguish couples who will conceive from those who will not. If there are multiple scores or probabilities, the sensitivity -specificity pairs for each cut-off value can be plotted in a receiver operating characteristic (ROC) curve ( Fig. 2a ) (Hanley and McNeil, 1982) . In that case, discrimination can be expressed as the area under this ROC curve (AUC) or the c-statistic (Tosteson et al., 1994 ). An AUC of 1 implies perfect discrimination, whereas an AUC of 0.5 means that the test does not discriminate at all (Hanley and McNeil, 1982) . For this review, a model is considered to have poor performance if the AUC lies between 0.50 and 0.70. An AUC between 0.70 and 0.80 represents fair performance, and an AUC between 0.80 and 0.90 represents good performance. Calibration refers to the level of correspondence between the calculated pregnancy chances and the observed proportion of pregnancies. Calibration can be evaluated by several techniques of which we will describe the three techniques that are most commonly used. The first technique relies on a goodness-of-fit test for the model for predicting pregnancy (Hosmer, 2000) . The second technique uses the coefficients of the linear regression line through the prediction-observation pairs in a calibration plot to evaluate the performance of a model. If the calibration is perfect, the line will be on the diagonal, with intercept zero and slope unity (Cox, 1958) . For models with a slope below 1, high-probability predictions are too high and low-probability predictions are too low. If the slope exceeds 1, the bias is the other way around (Steyerberg et (Fig. 2b) . A calibration plot is constructed by comparing the mean predicted probability (X-axis) with the observed proportion of pregnancies (Y-axis). For example, patients can be allocated to one of 10 groups of equal size on the basis of the deciles of the calculated probabilities. For each group, the mean predicted probability is calculated, as well as the observed proportion is calculated by Kaplan-Meier analysis. In case of perfect calibration, the predictionobservation pairs are on the main diagonal and confidence intervals are not overlapping. Points below the diagonal represent overestimation of the probability of pregnancy, and points above represent underestimation (Custers et al., 2007; van der Steeg et al., 2007) . When impact analysis was performed, we evaluated the correspondence between the calculated probabilities and the observed percentage of pregnancies after the introduction of the prediction models.
Results
Our search retrieved 1082 citations from MEDLINE and EMBASE, and none from the Cochrane Library. The process of selection of papers is summarized in Fig. 3 . We retrieved four papers from cross-references. After screening titles, abstracts and cross-references, we selected 70 papers for further reading. Exclusion criteria are shown in Fig. 3 
Prediction models in reproductive medicine
A total of 36 papers were included in our critical appraisal. Some papers discussed an existing model rather than a newly derived model and therefore the number of included models is lower than the number of included papers. There were 12 papers which reported on the prediction of treatment-independent pregnancy. In these papers, nine different prediction models were described. The 4 papers on models for the prediction of pregnancy after IUI reported on 3 different models, and the 20 papers for the prediction of pregnancy after IVF accounted for 17 different models. The characteristics of the studies in these papers are summarized for the different interventions in Tables I -III. The majority of studies were designed as a prospective cohort study. The inclusion criteria for the patients in the studies on the models for the prediction of treatment-independent pregnancy were generally subfertile couples, evaluated at a secondary or tertiary centre. Anovulation, azoospermia and tubal pathology were the most common exclusion criteria. The participants in the studies for the models of pregnancy after IUI or IVF mostly concerned couples within their first cycle, and in case of IVF, with or without assisted fertilization. A summary of the predictor variables and an estimate of the contribution made by each parameter to the prediction for the different models are shown in Tables IV -VI.
Study quality
An overview of the quality items per intervention is shown in Fig. 4a and b. Patient selection was consecutive in 7 (78%) models for of the treatment-independent pregnancy and in 18 (90%) of the treatment-dependent (IUI and IVF) models. Data collection was prospective in 8 (40%) of the treatment-dependent and in 6 (67%) of the models on treatment-independent pregnancy. Description of the variables for treatment was sufficient in 15 models for pregnancy after treatment (75%) and in 5 (56%) for the treatment-independent models. The description of pregnancy was given in almost comparable numbers of studies. Missing or imputation of missing data was reported for only a few models. Of all models for treatment-independent pregnancy, seven (78%) stated that they used Cox proportional hazards analysis, but only two (22%) described censoring. The amount of interventions between basic fertility work-up and time to pregnancy varied substantially between these models; the basic fertility work-up was clearly described in 67% of studies, and the follow-up duration was adequate in almost all of the studies. Of the treatment-dependent models, diagnosis before treatment was described in 14 (70%), and the protocol of treatment was described in 18 (90%).
Phases of development
The phases of development that the prediction models had passed are shown in Table VII . All models had passed development phase 1, as this was a criterion for inclusion in our review. Of the 29 models for prediction of pregnancy, 6 models had been validated only internally, and only 8 other models had passed the phase of external validation. One model had reached the phase of impact analysis.
Of the eight externally validated models, four models dealt with the prediction of treatment-independent pregnancy (Eimers et al., 1994; Collins et al., 1995; Snick et al., 1997; Hunault et al., 2004) , one model dealt with the prediction of pregnancy after IUI (Steures et al., 2004) and three models dealt with the prediction of pregnancy after IVF (Stolwijk et al., 1996; Templeton et al., 1996; Hunault et al., 2002a ). The only model that reached the phase of impact analysis was the model of Hunault et al. for the prediction of treatment-independent pregnancy.
Model performance
The performance of the eight models that were externally validated (Eimers et al., 1994; Collins et al., 1995; Stolwijk et al., 1996; Templeton et al., 1996; Snick et al., 1997; Hunault et al., 2002b; Hunault et al., 2004; Steures et al., 2004) is presented in Table VII . One model for the prediction of treatment-independent pregnancy (Hunault et al., 2004) had a poor discrimination (AUC 0.59), but good calibration. The other models for the prediction of treatment-independent pregnancy (Eimers et al., 1994; Collins et al., 1995; Snick et al., 1997) also had a poor discrimination (AUC ranging from 0.59 to 0.67) and did not perform well at calibration.
The one externally validated model for pregnancy after IUI (Steures et al., 2004) had poor discrimination (AUC 0.59), but good calibration; it could distinguish between a group with poor chances of pregnancy (0-5%) and a group with good chances of pregnancy (8-11%) (Custers et al., 2007) . Three models for the prediction of pregnancy after IVF had been externally validated (Stolwijk et al., 1996; Templeton et al., 1996; Hunault et al., 2002a) . The model of Templeton et al. had a poor discrimination with a c-statistic of 0.63, but differentiated reliably between women with a low and a relatively high probability of success with IVF (Smeenk et al., 2000) and was therefore to be considered of good calibration. The model of Stolwijk et al. had poor discrimination, with c-statistics ranging from 0.50 to 0.56. Calibration was also poor, because the model could not identify women with a (very) low probability of ongoing pregnancy after IVF (Stolwijk et al., 1998) . In the most recent validation of the model of Hunault et al. for the e BMI in four groups with reference category group 2 is BMI 18.5 to 25. f Developmental score is further adjusted with a more complex calculation Hunault (2002b) g IVF/ICSI cycles 1-2. h For age 30 years; HR is 1.68 for age 31 to 35 years. i OR ranging from 1.36 for a 2-cell good embryo to 2.32 for a 4-cell excellent embryo. j Age !38 years. k OR age 2 1006 (beta 0.00501) and OR age 3 1000 (beta 0.00261). l Model A: predictions at the start of the first IVF cycle. m Female age !38 years. n ,10 oocytes retrieved. o !1 oocyte retrieved or more than half of them fertilized. p Female age !36 years. q We calculated the ORs of the parameters as OR¼exp(b); the bs of the parameters were adopted from the models as stated in the respective papers. r Number of years of the female age over 25 years. prediction of pregnancy after IVF, a c-statistic of 0.63 was reported. However, the reported calibration was poor, because the difference between predicted and observed probabilities was significant (P , 0.001) . Impact analysis had been performed for the model of Hunault et al. for the prediction of treatment-independent pregnancy only, in a large cohort study with an embedded randomized trial . After the basic fertility work-up had been completed, a prognosis for treatment-independent pregnancy was calculated from the model (Hunault et al., 2004) . The prediction 'model' was transformed into a decision 'rule'. Couples with a good prognosis were counselled for expectant management, whereas couples with a poor prognosis were offered treatment. In the trial, only couples with an intermediate prognosis (a probability of 30 -40% for treatment-independent pregnancy within 12 months) were asked to participate in a randomized trial comparing IUI and expectant management. At six months, the ongoing pregnancy rates in both groups were 25%, which is comparable to the average calculated probability of 30-40% within 12 months.
Clinical application
The populations and outcomes are summarized per intervention in Tables I-III. To illustrate the possible use of the best performing models in clinical practice, we will present a potential clinical application for these models (Supplementary Material, Table S1 ). A general practitioner has referred a couple, where the 34-year-old ..........................................................................................................................................................................................   ........................................................................................................................................................................................... 
Continued
Prediction models in reproductive medicine woman has primary subfertility of 2 years' duration, to the gynaecologist. The results of the basic fertility work-up revealed no tubal pathology, no uterine abnormalities, but did disclose endometriosis. The post-coital test showed no progressive spermatozoa. The results of the semen analysis showed 40% progressive spermatozoa and no indications for male subfertility. The probability of a treatmentindependent pregnancy within 1 year was calculated as 25% using the model developed by Hunault et al. (2004) . The couple was advised to undergo six treatments of IUI with controlled ovarian stimulation. Using the model developed by Steures et al. (2004) , one can calculate the probability of pregnancy as 6.3% after one cycle. After unsuccessful IUI treatment, the couple started with IVF. The probability of pregnancy after IVF would be 16%, based on the model of Templeton et al. (1996) .
Discussion
In this review, of all derived prediction models in reproductive medicine, we identified 29 prediction models. We evaluated the models according to predefined phases of model development and looked systematically at their performance. Only eight models have been externally validated, and only three were found to be of good performance (Templeton et al., 1996; Hunault et al., 2004; Steures et al., 2004) . Only the model of Hunault et al. for treatment-independent pregnancy had reached the phase of impact analysis. Our evaluation of prediction models in reproductive medicine was complicated by three major issues. The first issue was the absence of a consensus on which performance measures to use for prediction models and how to interpret them. The AUC of most prediction models, for example, is low but there is a growing recognition that the ROC curve, which plays a central role in evaluating diagnostic models, has limitations in the evaluation of prediction models (Cook, 2007) . In contrast to diagnostic accuracy, prognostic accuracy is based on probabilities, and information is lost if the amount of difference between the predicted probabilities and the observed proportion is disregarded. In addition, with some exceptions, such as bilateral tubal obstruction and azoospermia, most couples who attend infertility clinics have some chance of conceiving, whereas on the other hand, even the most fertile couples never have a 100% chance of conception per cycle. Consequently, discrimination will always be imperfect and to use it as a test of a model's performance is not appropriate. Calibration is the most informative way of summarizing the performance of a model (Coppus et al., 2009) .
Calibration is evaluated by assessing the level of correspondence between the calculated pregnancy probabilities and the observed proportion of pregnancies. Well-calibrated models are able to classify individuals into clinically useful prognostic strata on the basis of the calculated probabilities of a pregnancy with and without treatment. This is illustrated by the external validation of the Templeton model for the prediction of pregnancy after IVF. The model differentiates between couples with a low and those with a relatively high probability of success after IVF, despite its limited discrimination between couples with and without success, with a c-statistic of 0.63 (Smeenk et al., 2000) .
The second issue was the lack of thorough external validation of the prediction models. The majority of the prediction models that were derived for pregnancy after IVF have not yet gone through an external validation. Good performance at external validation is a minimal requirement to be eligible for use in clinical practice. The third issue concerned the generalizability of the models across different patient profiles. The ideal prediction model should guide the gynaecologist to the best policy for a subfertile couple, selecting between expectant management, IUI or IVF. This prediction model should classify couples into groups with different prognoses. Unfortunately, at present it is not possible to calculate these probabilities for an individual couple directly after the completion of the basic fertility work-up. There is not one model for all policies, but there are different models for different policies. These models have been validated in different groups of patients. 2 Discrimination is reported as the AUC or as the c-statistic. 3 Results shown for the model without PCT (Hunault et al., 2004) . 4 The model only gave reliable predictions after adjustment of the average live birth rate. 5 Based on the model I of Stolwijk et al. (1996) .
The model for the prediction of pregnancy after IVF, for example, was derived and validated in a group of couples at the start of their first IVF cycle. That model has not yet been validated for the prediction of pregnancy after IVF in couples who have just completed the basic fertility work-up, and its performance in that population is unknown. The models that have been developed in reproductive medicine have reached only the phase of external validation at best, except for the model of Hunault et al., which has been used as one of the inclusion criteria in a randomized clinical trial. Further evaluation of model performance after external validation should be encouraged. One of the options is to use the model as a predictive marker in a randomized trial of expectant management versus either IUI or IVF. Such a trial has the advantage that a model can be evaluated for more than one treatment option in the same population, unlike the existing models, which have been evaluated in different patient populations. A second advantage is the fact that one could evaluate the use of the model as a predictive marker in what has been called a marker by treatment interaction design (Sargent et al., 2005; Lijmer and Bossuyt, 2009 ). In such an evaluation, one assesses whether the model is able to accurately identify patients who have better pregnancy chances with one of the treatment options compared with the alternative.
In conclusion, there are now three models with good predictive performance in reproductive medicine (Templeton et al., 1996; Hunault et al., 2004; Steures et al., 2004) . These models could be used as a guiding tool in making decisions about fertility treatment in patient couples similar to the development population. Yet, we should encourage further development of these existing models, as well as a more extensive documentation of their contribution to the improvement of the care for individual couples.
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